Apontis Pharma AG (ETR:APPH)
Germany
· Delayed Price · Currency is EUR 11.60
+0.10 (0.86%)
May 30, 2025, 5:36 PM CET
Apontis Pharma AG Market Cap
Apontis Pharma AG has a market cap or net worth of €96.63 million as of May 30, 2025. Its market cap has increased by 25.00% in one year.
Market Cap
96.63M
Enterprise Value
81.17M
Revenue
48.47M
Ranking
n/a
PE Ratio
128.23
Stock Price
€11.60
Market Cap Chart
Since May 11, 2021, Apontis Pharma AG's market cap has decreased from 159.38M to 96.63M, a decrease of -39.37%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 96.63M | 15.42% |
| Dec 30, 2024 | 83.72M | 111.58% |
| Dec 29, 2023 | 39.57M | -43.23% |
| Dec 30, 2022 | 69.70M | -59.00% |
| Dec 30, 2021 | 170.00M | 6.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.52B |
| Merck KGaA | 50.11B |
| Bayer Aktiengesellschaft | 24.29B |
| Fresenius SE & Co. KGaA | 23.87B |
| Fresenius Medical Care AG | 14.78B |
| Sartorius Aktiengesellschaft | 13.58B |
| Carl Zeiss Meditec AG | 5.09B |
| Fielmann Group AG | 4.69B |